Blastomycosis is a fungal infection caused by the inhalation of spores from the soil-dwelling fungus Blastomyces dermatitidis. This dimorphic fungus is endemic to certain regions in North America, particularly in areas with rich, acidic soil. The primary route of infection occurs through the respiratory system when individuals inhale airborne spores. Blastomycosis manifests as a spectrum of clinical presentations, ranging from asymptomatic or mild respiratory symptoms to severe and disseminated forms, involving multiple organ systems. The lungs are the initial site of infection, where the fungus transforms into yeast form and can subsequently disseminate to other organs, such as the skin, bones, and central nervous system. Diagnosing blastomycosis can be challenging due to its varied clinical manifestations and the lack of specific symptoms. Chest X-rays, fungal cultures, and molecular diagnostic tests are commonly employed to confirm the presence of Blastomyces dermatitidis. Antifungal medications, particularly itraconazole or amphotericin B, are the mainstay of treatment for blastomycosis. Severe cases may require prolonged and aggressive therapy. Despite treatment, some patients may experience relapses, emphasizing the need for ongoing monitoring and follow-up care.